
Steadicare Team — JUN 15, 2026
GLP-1 Receptor Agonists: What They Are and How They Work
An overview of GLP-1 agonists, their role in managing type 2 diabetes and obesity, and what patients should know before starting therapy.
Read moreSteadiCare is launching soon. Join the waitlist and be first in line.
Services are currently available to Texas residents only.
Explore breakthrough research, emerging therapies, and science-backed insights on peptides, longevity, healing, and human performance.

Steadicare Team — JUN 15, 2026
An overview of GLP-1 agonists, their role in managing type 2 diabetes and obesity, and what patients should know before starting therapy.
Read more
Steadicare Team — JUN 14, 2026
A practical overview of BPC-157, why patients ask about it for recovery, and what clinicians evaluate before recommending peptide therapy.
Read more
Steadicare Team — JUN 13, 2026
How TB-500 is discussed in regenerative medicine and questions to ask your provider.
Read more
Steadicare Team — JUN 12, 2026
Exploring thymosin beta-4 peptides, tissue regeneration, and clinician-led longevity care.
Read more
Steadicare Team — JUN 11, 2026
Beyond weight loss: cardiovascular, metabolic, and inflammatory pathways researchers are studying with GLP-1 therapies.
Read more